Table 2 Antibody responses against HTLV-1 HBZ
From: Humoral immune response to HTLV-1 basic leucine zipper factor (HBZ) in HTLV-1-infected individuals
All subjects^ | ||||
|---|---|---|---|---|
HTLV-1 Antibody | ND (n = 98) | AC (n = 145) | ATL (n = 89) | HAM/TSP (n = 104) |
Anti-HBZ | Â | Â | Â | Â |
Mean | 626.5 | 27102 | 8112 | 38413 |
Median | 99.0 | 375.9 | 256.6 | 692.2 |
Range | (0–6853) | (0–1180625) | (0–281419) | (0–815217) |
St. dev. | 1048 | 132838 | 37168 | 135893 |
Number of anti- | 0 | 15 | 11 | 14 |
HBZ + subjects (%)* | (0) | (10.34) | (12.36) | (13.46) |
ATL subtype | ||||
HTLV-1 Antibody | Acute (n = 30) | Chronic (n = 29) | Lymphoma (n = 30) | |
Anti-HBZ | Â | Â | Â | |
Mean | 7967 | 13413 | 3132 | |
Median | 165.1 | 535.0 | 166.0 | |
Range | (0–201062) | (0–281419) | (0–75697) | |
St. dev. | 36592 | 51994 | 13753 | |
Number of anti- | 3 | 7 | 1 | |
HBZ + subjects (%)* | (10.0) | (24.14) | (3.33) | |